STOCK TITAN

UiPath (PATH) SEC Filings

PATH NYSE

UiPath SEC filings document material events for an enterprise automation software company listed under PATH. Recent Form 8-K disclosures cover operating and financial results, executive leadership and compensation arrangements, annual meeting voting outcomes, and governance matters including director elections, advisory compensation votes, and auditor ratification.

The filings also record capital-structure subjects tied to UiPath's Class A and Class B common stock, including stockholder trading-plan disclosures. These records frame PATH's public-company reporting around results releases, board and officer matters, stockholder votes, and equity ownership structure.

Rhea-AI Summary

UiPath, Inc. (PATH) CPO & CTO Raghavendra Malpani sold 29,565 shares of Class A common stock on October 22, 2026, at $14.0018 per share. The transactions were made under a Rule 10b5-1 trading plan adopted by Malpani. After the sale, he directly held 1,484,716 shares. Reported transaction prices ranged from $14.0000 to $14.0100 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath, Inc. officer Raghavendra Malpani filed a notice of a proposed sale of 29,565 common shares, with an aggregate market value of $405,336.15 and an approximate sale date of October 22, 2026. The notice also reports three prior 10b5-1 sales: 29,564 shares on October 9, 40,464 on September 17, and 98,429 on September 16, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

UiPath, Inc. CEO and Chairman Daniel Dines reported sales of 2,500,000 Class A common shares across three transactions on October 15 and October 16, 2026. The reported per-share prices were $13.4449 for 1,250,000 shares on October 15; on October 16, they were $12.9787 for 1,202,400 shares and $13.8325 for 47,600 shares. The respective transaction price ranges were $13.0300 to $13.7050, $12.7300 to $13.7200, and $13.7300 to $13.9700. All three sales were made under a qualified selling plan adopted pursuant to Rule 10b5-1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath, Inc. (PATH) is the issuer for ICEVULCAN INVESTMENTS LIMITED’s proposed sale of 2,500,000 common shares, with an aggregate market value of $32,650,000 and an approximate sale date of October 15, 2026. Morgan Stanley Smith Barney LLC is listed as broker. ICEVULCAN INVESTMENTS LIMITED also reported selling 1,402,347 common shares on August 19, 2026, for gross proceeds of $22,539,362.39; these sales are identified as 10b5-1 sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Brad Brubaker, UiPath’s Chief Legal & Admin Officer, sold 27,404 shares of Class A Common Stock on October 12, 2026, at a reported $13.6314 per share. The sale was made under a Rule 10b5-1 trading plan. He reported 1,066,107 shares held directly after the sale. Prices for the reported transactions ranged from $13.5500 to $13.7300 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Raghavendra Malpani, UiPath, Inc.'s CPO & CTO, sold 29,564 shares of Class A Common Stock on October 9, 2026, at a reported price of $13.5051 per share. The sale was made pursuant to a Rule 10b5-1 trading plan. Prices for the reported transactions ranged from $13.5000 to $13.5200. Malpani directly held 1,514,281 shares after the sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath, Inc. (PATH) officer Brad C. Brubaker reported a sale of 27,404 common shares executed on October 12, 2026, with an aggregate market value of $369,405.92. Morgan Stanley Smith Barney LLC is listed as the broker.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

UiPath, Inc. officer Raghavendra Malpani reported a proposed sale of 29,564 common shares, with an aggregate market value of $391,723.00, for October 9, 2026, through Morgan Stanley Smith Barney LLC. The shares are listed as acquired from the issuer on October 1, 2026, through RSU/PSU. The notice also lists 10b5-1 sales of 40,464 shares for $566,552.82 on September 17, 2026, and 98,429 shares for $1,359,650.78 on September 16, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
other
-
Rhea-AI Summary

UiPath, Inc. COO Ashim Gupta reported selling 66,052 Class A common shares on October 2, 2026, at a reported $13.1680 per share under a qualified Rule 10b5-1 selling plan. The reported transaction prices ranged from $13.0200 to $13.3900. On October 1, 2026, the issuer withheld 12,266 shares to satisfy tax obligations on vested and settled performance stock units and 56,625 shares for tax obligations on vested and settled restricted stock units; both entries reported $12.8400 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
insider
Rhea-AI Summary

UiPath, Inc. (PATH) Chief Financial Officer Hitesh Ramani had 1,323 Class A common shares withheld by the issuer on October 1, 2026, to satisfy a tax obligation realized upon vesting and settlement of performance stock units. The issuer also withheld 29,297 Class A common shares on that date to satisfy a tax obligation realized upon vesting and settlement of restricted stock units. Both transactions were reported at $12.84 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
insider

FAQ

How many UiPath (PATH) SEC filings are available on StockTitan?

StockTitan tracks 204 SEC filings for UiPath (PATH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UiPath (PATH)?

The most recent SEC filing for UiPath (PATH) was filed on October 26, 2026.